Medical treatment of early breast cancer. III: chemotherapy.
about
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic CoHER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.
P2860
Medical treatment of early breast cancer. III: chemotherapy.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Medical treatment of early breast cancer. III: chemotherapy.
@ast
Medical treatment of early breast cancer. III: chemotherapy.
@en
Medical treatment of early breast cancer. III: chemotherapy.
@nl
type
label
Medical treatment of early breast cancer. III: chemotherapy.
@ast
Medical treatment of early breast cancer. III: chemotherapy.
@en
Medical treatment of early breast cancer. III: chemotherapy.
@nl
prefLabel
Medical treatment of early breast cancer. III: chemotherapy.
@ast
Medical treatment of early breast cancer. III: chemotherapy.
@en
Medical treatment of early breast cancer. III: chemotherapy.
@nl
P2860
P356
P1433
P1476
Medical treatment of early breast cancer. III: chemotherapy.
@en
P2093
P2860
P304
P356
10.1136/BMJ.332.7534.161
P407
P577
2006-01-01T00:00:00Z